{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:35:17Z","timestamp":1759178117853,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mechanisms responsible for macrovascular complications in diabetes remain to be fully understood. Recent studies have identified impaired vascular repair as a possible cause of plaque vulnerability in diabetes. This notion is supported by observations of a reduced content of fibrous proteins and smooth muscle cell mitogens in carotid endarterectomy from diabetic patients along with findings of decreased circulating levels of endothelial progenitor cells. In the present study we used a diabetic mouse model to characterize how hyperglycemia affects arterial repair responses. We induced atherosclerotic plaque formation in ApoE-deficient (ApoE\u2212\/\u2212) and heterozygous glucokinase knockout ApoE-deficient mice (ApoE\u2212\/\u2212 GK+\/\u2212) mice with a shear stress-modifying cast. There were no differences in cholesterol or triglyceride levels between the\u00a0ApoE\u2212\/\u2212 and ApoE\u2212\/\u2212 GK+\/\u2212 mice. Hyperglycemia did not affect the size of the formed atherosclerotic plaques, and no effects were seen on activation of cell proliferation, smooth muscle cell content or on the expression and localization of collagen, elastin and several other extracellular matrix proteins. The present study demonstrates that hyperglycemia per se has no significant effects on tissue repair processes in injured mouse carotid arteries, suggesting that other mechanisms are involved in diabetic plaque vulnerability.<\/jats:p>","DOI":"10.1038\/s41598-018-25942-3","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T15:14:40Z","timestamp":1525792480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hyperglycemia does not affect tissue repair responses in shear stress-induced atherosclerotic plaques in ApoE\u2212\/\u2212 mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Sabrina","family":"Hsiung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anki","family":"Knutsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenifer","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pontus","family":"Dun\u00e9r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvi E.","family":"Heinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Cathrine","family":"J\u00f6nsson-Rylander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-7479","authenticated-orcid":false,"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hultg\u00e5rdh-Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"25942_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00125-012-2817-5","volume":"56","author":"N Sattar","year":"2013","unstructured":"Sattar, N. Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia 56, 686\u2013695, https:\/\/doi.org\/10.1007\/s00125-012-2817-5 (2013).","journal-title":"Diabetologia"},{"key":"25942_CR2","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","volume":"100","author":"SM Grundy","year":"1999","unstructured":"Grundy, S. M. et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100, 1134\u20131146 (1999).","journal-title":"Circulation"},{"key":"25942_CR3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352, 1685\u20131695 (2005).","journal-title":"N Engl J Med"},{"key":"25942_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby, P., Ridker, P. M. & Maseri, A. Inflammation and atherosclerosis. Circulation 105, 1135\u20131143 (2002).","journal-title":"Circulation"},{"key":"25942_CR5","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman, J. A., Creager, M. A. & Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287, 2570\u20132581 (2002).","journal-title":"JAMA"},{"key":"25942_CR6","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","volume":"35","author":"I Goncalves","year":"2015","unstructured":"Goncalves, I. et al. Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes. Arterioscler Thromb Vasc Biol 35, 1723\u20131731, https:\/\/doi.org\/10.1161\/ATVBAHA.115.305631 (2015).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25942_CR7","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1161\/ATVBAHA.114.303414","volume":"34","author":"A Edsfeldt","year":"2014","unstructured":"Edsfeldt, A. et al. Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes. Arterioscler Thromb Vasc Biol 34, 2143\u20132150, https:\/\/doi.org\/10.1161\/ATVBAHA.114.303414 (2014).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25942_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","volume":"45","author":"GP Fadini","year":"2005","unstructured":"Fadini, G. P. et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45, 1449\u20131457, https:\/\/doi.org\/10.1016\/j.jacc.2004.11.067 (2005).","journal-title":"J Am Coll Cardiol"},{"key":"25942_CR9","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1161\/CIRCULATIONAHA.107.746008","volume":"117","author":"G Foteinos","year":"2008","unstructured":"Foteinos, G., Hu, Y., Xiao, Q., Metzler, B. & Xu, Q. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117, 1856\u20131863, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.746008 (2008).","journal-title":"Circulation"},{"key":"25942_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa043814","volume":"353","author":"N Werner","year":"2005","unstructured":"Werner, N. et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353, 999\u20131007, https:\/\/doi.org\/10.1056\/NEJMoa043814 (2005).","journal-title":"N Engl J Med"},{"key":"25942_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2337\/db15-0517","volume":"65","author":"SR Thom","year":"2016","unstructured":"Thom, S. R. et al. Measurements of CD34+\/CD45-dim Stem Cells Predict Healing of Diabetic Neuropathic Wounds. Diabetes 65, 486\u2013497, https:\/\/doi.org\/10.2337\/db15-0517 (2016).","journal-title":"Diabetes"},{"key":"25942_CR12","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","volume":"92","author":"J Lennartsson","year":"2012","unstructured":"Lennartsson, J. & Ronnstrand, L. Stem cell factor receptor\/c-Kit: from basic science to clinical implications. Physiol Rev 92, 1619\u20131649, https:\/\/doi.org\/10.1152\/physrev.00046.2011 (2012).","journal-title":"Physiol Rev"},{"key":"25942_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/joim.12675","volume":"282","author":"H Bjorkbacka","year":"2017","unstructured":"Bjorkbacka, H. et al. Plasma stem cell factor levels are associated with risk of cardiovascular disease and death. J Intern Med 282, 508\u2013521, https:\/\/doi.org\/10.1111\/joim.12675 (2017).","journal-title":"J Intern Med"},{"key":"25942_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1161\/01.ATV.0000257148.01384.7d","volume":"27","author":"CH Wang","year":"2007","unstructured":"Wang, C. H. et al. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 27, 540\u2013547, https:\/\/doi.org\/10.1161\/01.ATV.0000257148.01384.7d (2007).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25942_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1586\/14779072.2014.930664","volume":"12","author":"G Kassimis","year":"2014","unstructured":"Kassimis, G., De Maria, G. L., Patel, N. & Banning, A. P. Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving? Expert Rev Cardiovasc Ther 12, 997\u20131003, https:\/\/doi.org\/10.1586\/14779072.2014.930664 (2014).","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"25942_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/j.1463-1326.2007.00819.x","volume":"10","author":"T Gorman","year":"2008","unstructured":"Gorman, T. et al. Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice. Diabetes Obes Metab 10, 885\u2013897, https:\/\/doi.org\/10.1111\/j.1463-1326.2007.00819.x (2008).","journal-title":"Diabetes Obes Metab"},{"key":"25942_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1210\/er.2006-0035","volume":"28","author":"SM Clee","year":"2007","unstructured":"Clee, S. M. & Attie, A. D. The genetic landscape of type 2 diabetes in mice. Endocr Rev 28, 48\u201383, https:\/\/doi.org\/10.1210\/er.2006-0035 (2007).","journal-title":"Endocr Rev"},{"key":"25942_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJ King","year":"2012","unstructured":"King, A. J. The use of animal models in diabetes research. Br J Pharmacol 166, 877\u2013894, https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01911.x (2012).","journal-title":"Br J Pharmacol"},{"key":"25942_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/1358863X08094801","volume":"14","author":"E Adiguzel","year":"2009","unstructured":"Adiguzel, E., Ahmad, P. J., Franco, C. & Bendeck, M. P. Collagens in the progression and complications of atherosclerosis. Vasc Med 14, 73\u201389, https:\/\/doi.org\/10.1177\/1358863X08094801 (2009).","journal-title":"Vasc Med"},{"key":"25942_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1152\/physrev.00041.2003","volume":"84","author":"GK Owens","year":"2004","unstructured":"Owens, G. K., Kumar, M. S. & Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767\u2013801, https:\/\/doi.org\/10.1152\/physrev.00041.2003 (2004).","journal-title":"Physiol Rev"},{"key":"25942_CR21","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jcb.10413","volume":"88","author":"HM Kagan","year":"2003","unstructured":"Kagan, H. M. & Li, W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 88, 660\u2013672, https:\/\/doi.org\/10.1002\/jcb.10413 (2003).","journal-title":"J Cell Biochem"},{"key":"25942_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2741\/3365","volume":"14","author":"LH Engelholm","year":"2009","unstructured":"Engelholm, L. H. et al. The collagen receptor uPARAP\/Endo180. Front Biosci (Landmark Ed) 14, 2103\u20132114 (2009).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"25942_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/joim.12400","volume":"278","author":"A Hultgardh-Nilsson","year":"2015","unstructured":"Hultgardh-Nilsson, A., Boren, J. & Chakravarti, S. The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis. J Intern Med 278, 447\u2013461, https:\/\/doi.org\/10.1111\/joim.12400 (2015).","journal-title":"J Intern Med"},{"key":"25942_CR24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1161\/01.RES.0000126921.29919.51","volume":"94","author":"TN Wight","year":"2004","unstructured":"Wight, T. N. & Merrilees, M. J. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ Res 94, 1158\u20131167, https:\/\/doi.org\/10.1161\/01.RES.0000126921.29919.51 (2004).","journal-title":"Circ Res"},{"key":"25942_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341\u2013355, https:\/\/doi.org\/10.1016\/j.cell.2011.04.005 (2011).","journal-title":"Cell"},{"key":"25942_CR26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/intimm\/dxt043","volume":"25","author":"K Tse","year":"2013","unstructured":"Tse, K., Tse, H., Sidney, J., Sette, A. & Ley, K. T cells in atherosclerosis. Int Immunol 25, 615\u2013622, https:\/\/doi.org\/10.1093\/intimm\/dxt043 (2013).","journal-title":"Int Immunol"},{"key":"25942_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","volume":"12","author":"GK Hansson","year":"2011","unstructured":"Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat Immunol 12, 204\u2013212, https:\/\/doi.org\/10.1038\/ni.2001 (2011).","journal-title":"Nat Immunol"},{"key":"25942_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson, D. & Rayfield, E. J. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol 1, 1 (2002).","journal-title":"Cardiovasc Diabetol"},{"key":"25942_CR29","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2337\/db07-1808","volume":"57","author":"A Soro-Paavonen","year":"2008","unstructured":"Soro-Paavonen, A. et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 57, 2461\u20132469, https:\/\/doi.org\/10.2337\/db07-1808 (2008).","journal-title":"Diabetes"},{"key":"25942_CR30","doi-asserted-by":"publisher","first-page":"2543268","DOI":"10.1155\/2016\/2543268","volume":"2016","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. The Role of HMGB1 in the Pathogenesis of Type 2 Diabetes. J Diabetes Res 2016, 2543268, https:\/\/doi.org\/10.1155\/2016\/2543268 (2016).","journal-title":"J Diabetes Res"},{"key":"25942_CR31","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1053\/ajkd.1998.v32.pm9820468","volume":"32","author":"PW Wilson","year":"1998","unstructured":"Wilson, P. W. Diabetes mellitus and coronary heart disease. Am J Kidney Dis 32, S89\u2013100 (1998).","journal-title":"Am J Kidney Dis"},{"key":"25942_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fendo.2013.00037","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf, M. E. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne) 4, 37, https:\/\/doi.org\/10.3389\/fendo.2013.00037 (2013).","journal-title":"Front Endocrinol (Lausanne)"},{"key":"25942_CR33","doi-asserted-by":"publisher","first-page":"42351","DOI":"10.1074\/jbc.R400019200","volume":"279","author":"RP Robertson","year":"2004","unstructured":"Robertson, R. P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279, 42351\u201342354, https:\/\/doi.org\/10.1074\/jbc.R400019200 (2004).","journal-title":"J Biol Chem"},{"key":"25942_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrd4275","volume":"13","author":"MY Donath","year":"2014","unstructured":"Donath, M. Y. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov 13, 465\u2013476, https:\/\/doi.org\/10.1038\/nrd4275 (2014).","journal-title":"Nat Rev Drug Discov"},{"key":"25942_CR35","doi-asserted-by":"publisher","first-page":"8630961","DOI":"10.1155\/2016\/8630961","volume":"2016","author":"DD Adingupu","year":"2016","unstructured":"Adingupu, D. D. et al. Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice. J Diabetes Res 2016, 8630961, https:\/\/doi.org\/10.1155\/2016\/8630961 (2016).","journal-title":"J Diabetes Res"},{"key":"25942_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00268-003-7397-6","volume":"28","author":"A Gosain","year":"2004","unstructured":"Gosain, A. & DiPietro, L. A. Aging and wound healing. World J Surg 28, 321\u2013326, https:\/\/doi.org\/10.1007\/s00268-003-7397-6 (2004).","journal-title":"World J Surg"},{"key":"25942_CR37","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1161\/01.ATV.0000245830.29764.84","volume":"26","author":"AK Robertson","year":"2006","unstructured":"Robertson, A. K. & Hansson, G. K. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 26, 2421\u20132432, https:\/\/doi.org\/10.1161\/01.ATV.0000245830.29764.84 (2006).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25942_CR38","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1100\/tsw.2007.117","volume":"7","author":"P Lindstrom","year":"2007","unstructured":"Lindstrom, P. The physiology of obese-hyperglycemic mice [ob\/ob mice]. ScientificWorldJournal 7, 666\u2013685, https:\/\/doi.org\/10.1100\/tsw.2007.117 (2007).","journal-title":"ScientificWorldJournal"},{"key":"25942_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.atherosclerosis.2005.02.024","volume":"182","author":"P Otero","year":"2005","unstructured":"Otero, P., Bonet, B., Herrera, E. & Rabano, A. Development of atherosclerosis in the diabetic BALB\/c mice. Prevention with Vitamin E administration. Atherosclerosis 182, 259\u2013265, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.02.024 (2005).","journal-title":"Atherosclerosis"},{"key":"25942_CR40","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.2337\/diabetes.49.6.1064","volume":"49","author":"P Keren","year":"2000","unstructured":"Keren, P. et al. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 49, 1064\u20131069 (2000).","journal-title":"Diabetes"},{"key":"25942_CR41","doi-asserted-by":"publisher","first-page":"176162","DOI":"10.1155\/2012\/176162","volume":"2012","author":"D Engelbertsen","year":"2012","unstructured":"Engelbertsen, D. et al. Increased inflammation in atherosclerotic lesions of diabetic Akita-LDLr(\u2212)\/(\u2212) mice compared to nondiabetic LDLr(\u2212)\/(\u2212) mice. Exp Diabetes Res 2012, 176162, https:\/\/doi.org\/10.1155\/2012\/176162 (2012).","journal-title":"Exp Diabetes Res"},{"key":"25942_CR42","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/2012","volume":"4","author":"L Park","year":"1998","unstructured":"Park, L. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4, 1025\u20131031, https:\/\/doi.org\/10.1038\/2012 (1998).","journal-title":"Nat Med"},{"key":"25942_CR43","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s00125-015-3637-1","volume":"58","author":"RH Al-Mashhadi","year":"2015","unstructured":"Al-Mashhadi, R. H. et al. Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs. Diabetologia 58, 1926\u20131936, https:\/\/doi.org\/10.1007\/s00125-015-3637-1 (2015).","journal-title":"Diabetologia"},{"key":"25942_CR44","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1161\/01.ATV.17.10.2250","volume":"17","author":"P Reaven","year":"1997","unstructured":"Reaven, P., Merat, S., Casanada, F., Sutphin, M. & Palinski, W. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 17, 2250\u20132256 (1997).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"25942_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI200417867","volume":"114","author":"CB Renard","year":"2004","unstructured":"Renard, C. B. et al. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114, 659\u2013668, https:\/\/doi.org\/10.1172\/JCI17867 (2004).","journal-title":"J Clin Invest"},{"key":"25942_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.kisu.2017.10.003","volume":"8","author":"F Persson","year":"2018","unstructured":"Persson, F. & Rossing, P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney International Supplements 8, 2\u20137, https:\/\/doi.org\/10.1016\/j.kisu.2017.10.003 (2018).","journal-title":"Kidney International Supplements"},{"key":"25942_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2014.05.964","volume":"237","author":"H Adachi","year":"2014","unstructured":"Adachi, H. Microalbuminuria is an independent prognostic information for cardiovascular disease. Atherosclerosis 237, 106\u2013107, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.964 (2014).","journal-title":"Atherosclerosis"},{"key":"25942_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jama.2013.283980","volume":"311","author":"AM Steele","year":"2014","unstructured":"Steele, A. M. et al. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 311, 279\u2013286, https:\/\/doi.org\/10.1001\/jama.2013.283980 (2014).","journal-title":"JAMA"},{"key":"25942_CR49","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","volume":"27","author":"RM Krauss","year":"2004","unstructured":"Krauss, R. M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27, 1496\u20131504 (2004).","journal-title":"Diabetes Care"},{"key":"25942_CR50","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1161\/CIRCULATIONAHA.105.590018","volume":"113","author":"C Cheng","year":"2006","unstructured":"Cheng, C. et al. Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation 113, 2744\u20132753, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.590018 (2006).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25942-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25942-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25942-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:13:26Z","timestamp":1671599606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-25942-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["25942"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-25942-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7530"}}